Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 111751-111800 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03108456
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
NAActive, not recruiting
2,005 participants
Started: Mar 27, 2017 · Completed: Jun 12, 2025
3 conditions2 sponsors104 locations
NCT03037684
Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
N/ARecruiting
75 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03071666
Vitamin B12 Supplementation During Pregnancy on Cognitive Development
PHASE2/PHASE3Active, not recruiting
800 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2029
3 conditions4 sponsors1 location
NCT02979977
Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck
PHASE2Active, not recruiting
50 participants
Started: Mar 24, 2017 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT03048201
Physica System Total Knee Replacement Registry Study
NARecruiting
800 participants
Started: Mar 24, 2017 · Completed: Mar 31, 2030
6 conditions1 sponsor5 locations
NCT03036098
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
PHASE3Active, not recruiting
1,314 participants
Started: Mar 24, 2017 · Completed: Nov 24, 2025
1 condition2 sponsors174 locations
NCT02949219
Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
PHASE2Active, not recruiting
41 participants
Started: Mar 24, 2017 · Completed: Dec 31, 2024
3 conditions2 sponsors8 locations
NCT05250375
Natural History Study of Mitochondrial Myopathy
N/ARecruiting
1,300 participants
Started: Mar 24, 2017 · Completed: Mar 24, 2030
1 condition5 sponsors1 location
NCT03819738
fMRI in Deep Brain Stimulation
NARecruiting
20 participants
Started: Mar 24, 2017 · Completed: Jan 10, 2025
2 conditions1 sponsor1 location
NCT05362136
Effect of Multiple Perforations of the Sinus Floor on Bone Formation After Sinus Floor Elevation
NARecruiting
12 participants
Started: Mar 23, 2017 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT02503722
Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer
PHASE1Active, not recruiting
36 participants
Started: Mar 23, 2017 · Completed: Jun 5, 2026
6 conditions1 sponsor5 locations
NCT06136897
Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)
PHASE2Active, not recruiting
35 participants
Started: Mar 23, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03703947
Biomarker Profiling in Abdominal Aortic Aneurysm Patients
N/ARecruiting
440 participants
Started: Mar 23, 2017 · Completed: Aug 31, 2024
1 condition2 sponsors2 locations
NCT03131531
Bergamo Lymphoid Cancer Registry
N/ARecruiting
6,000 participants
Started: Mar 23, 2017 · Completed: Mar 23, 2037
3 conditions1 sponsor1 location
NCT02900976
Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder
PHASE2Active, not recruiting
18 participants
Started: Mar 22, 2017 · Completed: Sep 22, 2025
7 conditions2 sponsors38 locations
NCT06390839
Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)
PHASE2Active, not recruiting
43 participants
Started: Mar 22, 2017 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03025334
tDCS on Parkinson's Disease Cognition
NARecruiting
36 participants
Started: Mar 22, 2017 · Completed: Aug 31, 2025
2 conditions2 sponsors1 location
NCT03079011
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
PHASE3Active, not recruiting
1,017 participants
Started: Mar 22, 2017 · Completed: Jun 30, 2025
1 condition2 sponsors82 locations
NCT03090646
Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance
NAActive, not recruiting
320 participants
Started: Mar 22, 2017 · Completed: Aug 1, 2026
3 conditions3 sponsors2 locations
NCT03093922
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
PHASE2Active, not recruiting
32 participants
Started: Mar 22, 2017 · Completed: Mar 31, 2026
3 conditions5 sponsors9 locations
NCT05511688
National Cohort of Colorectal Cancers With Microsatellite Instability
N/AActive, not recruiting
637 participants
Started: Mar 22, 2017 · Completed: Dec 31, 2025
2 conditions1 sponsor14 locations
NCT03145077
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
NARecruiting
1,400 participants
Started: Mar 21, 2017 · Completed: May 31, 2027
1 condition3 sponsors1 location
NCT02899221
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
NAActive, not recruiting
3 participants
Started: Mar 21, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02929732
Analysis of Sympathetic Activity in Willis-Ekbom Disease
NARecruiting
40 participants
Started: Mar 21, 2017 · Completed: Oct 5, 2027
2 conditions1 sponsor1 location
NCT06940323
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
N/ARecruiting
250 participants
Started: Mar 21, 2017 · Completed: Jun 30, 2035
4 conditions1 sponsor1 location
NCT03067051
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
PHASE1/PHASE2Recruiting
66 participants
Started: Mar 21, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT03121001
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
PHASE2Recruiting
50 participants
Started: Mar 20, 2017 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT03024385
Interconception Care at the University of Mississippi Medical Center
N/AEnrolling by invitation
1,625 participants
Started: Mar 20, 2017 · Completed: Jan 31, 2026
2 conditions3 sponsors1 location
NCT01422746
Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
EARLY_PHASE1Recruiting
20 participants
Started: Mar 20, 2017 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT03032627
Identifying Targets of Maladaptive Metabolic Responses in Heart Failure
NAActive, not recruiting
55 participants
Started: Mar 20, 2017 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT03466476
TracPatch in Total Knee Arthroplasty
NAActive, not recruiting
150 participants
Started: Mar 20, 2017 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT03488966
Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients
NAActive, not recruiting
85 participants
Started: Mar 20, 2017 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03128996
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
PHASE1/PHASE2Recruiting
29 participants
Started: Mar 20, 2017 · Completed: Apr 30, 2031
6 conditions1 sponsor3 locations
NCT03562169
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
PHASE3Recruiting
406 participants
Started: Mar 20, 2017 · Completed: Mar 31, 2027
1 condition3 sponsors91 locations
NCT03026998
MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)
NAActive, not recruiting
88 participants
Started: Mar 19, 2017 · Completed: Mar 31, 2034
1 condition1 sponsor1 location
NCT03066206
Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
PHASE2Active, not recruiting
93 participants
Started: Mar 17, 2017 · Completed: Dec 31, 2025
4 conditions3 sponsors1 location
NCT03008525
Vitamin D and Its Metabolites Quantification in Adipose Tissues of Obese and Non-obese Patients.
NARecruiting
60 participants
Started: Mar 17, 2017 · Completed: Sep 13, 2026
1 condition1 sponsor1 location
NCT04308330
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
PHASE1Recruiting
30 participants
Started: Mar 17, 2017 · Completed: Dec 31, 2024
6 conditions1 sponsor1 location
NCT06000020
Leave or Laparoscopic Appendectomy With Normal Findings - a Regional Cohort Study
N/AActive, not recruiting
1,400 participants
Started: Mar 17, 2017 · Completed: Apr 1, 2026
1 condition1 sponsor4 locations
NCT02899312
PSMA PET/CT for Assessment of Recurrent Prostate Cancer
N/AActive, not recruiting
2,244 participants
Started: Mar 16, 2017 · Completed: Jun 30, 2030
2 conditions1 sponsor1 location
NCT02986516
Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease
NARecruiting
100 participants
Started: Mar 16, 2017 · Completed: Sep 30, 2025
1 condition1 sponsor28 locations
NCT02646384
Ovarian Tissue Cryopreservation in Children
NAActive, not recruiting
100 participants
Started: Mar 16, 2017 · Completed: Jan 22, 2040
1 condition1 sponsor1 location
NCT03085875
POWERMOM, A Healthy Pregnancy Research Community
N/ARecruiting
100,000 participants
Started: Mar 16, 2017 · Completed: Jul 31, 2027
4 conditions1 sponsor1 location
NCT03085147
A Dye for the Detection of Cancer of the Tongue and Mouth
PHASE1/PHASE2Active, not recruiting
23 participants
Started: Mar 15, 2017 · Completed: Jul 31, 2026
1 condition1 sponsor7 locations
NCT03442504
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NAActive, not recruiting
57 participants
Started: Mar 15, 2017 · Completed: Jun 30, 2024
1 condition1 sponsor4 locations
NCT03085056
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
EARLY_PHASE1Active, not recruiting
13 participants
Started: Mar 15, 2017 · Completed: Sep 30, 2026
1 condition2 sponsors7 locations
NCT03085173
"A Trial of Armored CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies"
PHASE1Active, not recruiting
39 participants
Started: Mar 15, 2017 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT03707769
TIPS Microspheres for Perianal Fistula
NAActive, not recruiting
13 participants
Started: Mar 15, 2017 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT03071406
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
PHASE2Active, not recruiting
50 participants
Started: Mar 14, 2017 · Completed: Oct 31, 2025
2 conditions2 sponsors2 locations
NCT02344355
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PHASE2Active, not recruiting
90 participants
Started: Mar 13, 2017 · Completed: Dec 31, 2027
1 condition4 sponsors1 location